Table of Contents Europe Ophthalmic Therapeutic Drugs Market Report 2012-2023 1 Ophthalmic Therapeutic Drugs Overview 1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs 1.2 Classification of Ophthalmic Therapeutic Drugs by Product Category 1.2.1 Europe Ophthalmic Therapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 by Therapeutic Class 1.2.4 Anti-inflammatory Drugs 1.2.5 Anti-infective Drugs 1.2.6 Anti-glaucoma Drugs 1.2.7 Anti-allergy Drugs 1.2.8 Anti-VEGF Agents 1.2.9 ????????Others 1.2.10 ????by Product Type 1.2.11 ????????Prescription Drugs 1.2.12 ????????Over-the-Counter Drugs 1.3 Europe Ophthalmic Therapeutic Drugs Market by Application/End Users 1.3.1 Europe Ophthalmic Therapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Independent Pharmacies & Drug Stores 1.4 Europe Ophthalmic Therapeutic Drugs Market by Region 1.4.1 Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Ophthalmic Therapeutic Drugs (2012-2023) 1.5.1 Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Ophthalmic Therapeutic Drugs 2.2 Raw Material Analysis of Ophthalmic Therapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Ophthalmic Therapeutic Drugs 2.4 Other Costs Analysis of Ophthalmic Therapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Ophthalmic Therapeutic Drugs 2.6 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs 2.7 Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Ophthalmic Therapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Bayer 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Bayer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Bayer Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Bayer Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.2 Pfizer 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Pfizer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Pfizer Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Pfizer Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Novartis Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Novartis Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.4 ALLERGAN 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 ALLERGAN Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 ALLERGAN Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Aerie Pharmaceuticals 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Aerie Pharmaceuticals Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Valeant Pharmaceuticals International 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Valeant Pharmaceuticals International Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Genentech 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Genentech Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Genentech Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Genentech Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.8 Regeneron Pharmaceuticals 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Regeneron Pharmaceuticals Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.9 Shire 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Shire Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Shire Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Shire Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Santen Pharmaceutical 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Santen Pharmaceutical Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 4 Europe Ophthalmic Therapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Ophthalmic Therapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Ophthalmic Therapeutic Drugs Sales and Revenue by Type 4.2.1 Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Ophthalmic Therapeutic Drugs Sales and Revenue by Application 4.3.1 Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Ophthalmic Therapeutic Drugs Sales (K Units) by Application 5 Germany Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 5.1 Germany Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 5.1.1 Germany Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Germany Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 5.3 Germany Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 6 UK Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 6.1 UK Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 6.1.1 UK Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 UK Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 6.3 UK Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 7 France Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 7.1 France Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 7.1.1 France Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 France Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 7.3 France Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 8 Russia Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 8.1 Russia Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 8.1.1 Russia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Russia Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 8.3 Russia Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 9 Benelux Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 9.1 Benelux Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 9.1.1 Benelux Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 9.3 Benelux Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 10 Italy Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 10.1 Italy Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 10.1.1 Italy Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Italy Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 10.3 Italy Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 11 Spain Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 11.1 Spain Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 11.1.1 Spain Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Spain Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 11.3 Spain Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Ophthalmic Therapeutic Drugs Market Forecast (2018-2023) 13.1 Europe Ophthalmic Therapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Ophthalmic Therapeutic Drugs Price and Trend Forecast (2018-2023) 13.2 Europe Ophthalmic Therapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Ophthalmic Therapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Ophthalmic Therapeutic Drugs Sales Forecast by Type (2018-2023) 13.3.2 Europe Ophthalmic Therapeutic Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Europe Ophthalmic Therapeutic Drugs Price Forecast by Type (2018-2023) 13.4 Europe Ophthalmic Therapeutic Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Ophthalmic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Ophthalmic Therapeutic Drugs Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Ophthalmic Therapeutic Drugs by Applications in 2017 Table Europe Market Ophthalmic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure France Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Ophthalmic Therapeutic Drugs Table Industry News List of Ophthalmic Therapeutic Drugs Figure Industry Chain Structure of Ophthalmic Therapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Ophthalmic Therapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs Table Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers Europe Table Major Buyers of Ophthalmic Therapeutic Drugs Table Bayer Basic Information List Table Bayer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Bayer Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Bayer Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Bayer Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Bayer Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Pfizer Basic Information List Table Pfizer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Pfizer Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Pfizer Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Pfizer Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Novartis Basic Information List Table Novartis Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Novartis Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Novartis Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Novartis Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table ALLERGAN Basic Information List Table ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ALLERGAN Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure ALLERGAN Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure ALLERGAN Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ALLERGAN Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table ALLERGAN Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table ALLERGAN Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Aerie Pharmaceuticals Basic Information List Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Valeant Pharmaceuticals International Basic Information List Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Genentech Basic Information List Table Genentech Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Genentech Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Genentech Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Genentech Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Genentech Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Genentech Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Genentech Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Regeneron Pharmaceuticals Basic Information List Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Shire Basic Information List Table Shire Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Shire Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Shire Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Shire Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Shire Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Shire Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Shire Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Company Santen Pharmaceutical Basic Information List Table Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Volume in Hospital Pharmacies and Its Application Share Table Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Volume in Online Pharmacies and Its Application Share Table Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Volume in Independent Pharmacies & Drug Stores and Its Application Share Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Ophthalmic Therapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Ophthalmic Therapeutic Drugs Sales Share by Players/Manufacturers Table Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Ophthalmic Therapeutic Drugs Revenue Market Share (%) Players Figure 2017 Europe Ophthalmic Therapeutic Drugs Revenue Market Share (%) Players Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Type (2012-2017) Figure Europe Ophthalmic Therapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Ophthalmic Therapeutic Drugs by Type (2012-2017) Figure Europe Ophthalmic Therapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Regions (2012-2017) Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share by Regions in 2017 Table Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Ophthalmic Therapeutic Drugs by Regions (2012-2017) Figure Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Regions in 2017 Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Europe Ophthalmic Therapeutic Drugs Sales Share (%) by Application (2012-2017) Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure Germany Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Germany Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Germany Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Germany Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Germany Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Germany Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure UK Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure UK Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table UK Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table UK Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure UK Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table UK Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table UK Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure UK Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure France Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure France Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table France Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table France Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure France Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table France Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table France Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure France Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Russia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Russia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Russia Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Russia Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Russia Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Russia Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Russia Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Italy Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Italy Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Italy Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Italy Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Italy Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Italy Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Italy Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Benelux Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Benelux Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Benelux Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Benelux Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Spain Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Spain Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Spain Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Spain Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Spain Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Spain Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Spain Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Price and Trend Forecast (2018-2023) Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure Germany Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table Europe Ophthalmic Therapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Bayer Pfizer Novartis ALLERGAN Aerie Pharmaceuticals Valeant Pharmaceuticals International Genentech Regeneron Pharmaceuticals Shire Santen Pharmaceutical